Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence

[1]  J. Sirviö,et al.  Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task , 1998, Neuroscience.

[2]  Z. Szabo,et al.  Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.

[3]  F. Schifano,et al.  MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. , 1998, Drug and alcohol dependence.

[4]  M. Forsling,et al.  Low-dose MDMA (“ecstasy”) induces vasopressin secretion , 1998, The Lancet.

[5]  J. Holden,et al.  Relations between PET-derived measures of thalamic glucose metabolism and EEG alpha power. , 1998, Psychophysiology.

[6]  Ramesh Srinivasan,et al.  Estimating the spatial Nyquist of the human EEG , 1998 .

[7]  D Liberati,et al.  EEG coherence in Alzheimer's disease. , 1998, Electroencephalography and clinical neurophysiology.

[8]  A. Lees,et al.  Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.

[9]  M. Ho,et al.  Effect of central 5-hydroxytryptamine depletion on performance in the “time-left” procedure: further evidence for a role of the 5-hydroxytryptaminergic pathways in behavioural “switching” , 1997, Psychopharmacology.

[10]  H. Curran,et al.  Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. , 1997, Addiction.

[11]  W. Lutzenberger,et al.  EEG alpha dynamics as viewed from EEG dimension dynamics. , 1997, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[12]  T. Baldeweg,et al.  Alpha EEG activity and subcortical pathology in HIV infection. , 1997, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[13]  J. Raz,et al.  Intra-hemispheric alpha coherence decreases with increasing cognitive impairment in HIV patients. , 1997, Electroencephalography and clinical neurophysiology.

[14]  M. Paule,et al.  Effects of MDMA on Complex Brain Function in Laboratory Animals , 1997, Neuroscience & Biobehavioral Reviews.

[15]  Frank H. Duffy,et al.  Effects of age upon interhemispheric EEG coherence in normal adults , 1996, Neurobiology of Aging.

[16]  G. Goodwin,et al.  Ecstasy and neurodegeneration , 1996, BMJ.

[17]  A. Leuchter,et al.  Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG , 1996, Behavioural Brain Research.

[18]  R. Dafters.  Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing , 1995, Physiology & Behavior.

[19]  H N Wagner,et al.  Positron Emission Tomography of 5-HT Transporter Sites in the Baboon Brain with [11C]McN5652 , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  W. Slikker,et al.  Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. , 1995, Neurotoxicology and teratology.

[21]  Zsolt Szabo,et al.  Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652 , 1995, Synapse.

[22]  A. Leuchter,et al.  Effect of white matter disease on functional connections in the aging brain. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[23]  F H Duffy,et al.  Status of Quantitative EEG (QEEG) in Clinical Practice, 1994 , 1994, Clinical EEG.

[24]  A. Leuchter,et al.  Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part II: Two-Year Follow-Up of Patients With Depression. , 1994, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[25]  Y. Shaham,et al.  Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans , 1994, Neuropsychopharmacology.

[26]  B. Kessel.  Hyponatraemia after ingestion of “ectasy” , 1994 .

[27]  D O Walter,et al.  Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. , 1993, Electroencephalography and clinical neurophysiology.

[28]  D. Tucker.  Spatial sampling of head electrical fields: the geodesic sensor net. , 1993, Electroencephalography and clinical neurophysiology.

[29]  Frank H. Duffy,et al.  The pattern of age-related differences in electrophysiological activity of healthy males and females , 1993, Neurobiology of Aging.

[30]  S. Dawling,et al.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") , 1992, The Lancet.

[31]  U. McCann,et al.  Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humans a , 1992, Annals of the New York Academy of Sciences.

[32]  U. McCann,et al.  Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users. , 1991, Journal of clinical psychopharmacology.

[33]  J. Kehne,et al.  Neurotoxicity of MDMA: Neurochemical Effects , 1990, Annals of the New York Academy of Sciences.

[34]  L. Schneider,et al.  EEG amplitudes in healthy, late-middle-aged and elderly adults: normality of the distributions and correlations with age. , 1990, Electroencephalography and clinical neurophysiology.

[35]  Jeffrey B. Henriques,et al.  Regional brain electrical asymmetries discriminate between previously depressed and healthy control subjects. , 1990, Journal of abnormal psychology.

[36]  R. Engle,et al.  Is working memory capacity task dependent , 1989 .

[37]  G Fein,et al.  Common reference coherence data are confounded by power and phase effects. , 1988, Electroencephalography and clinical neurophysiology.

[38]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[39]  D. O. Walter,et al.  Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study. , 1987, Archives of general psychiatry.

[40]  D. Charney,et al.  Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine. , 1986, Archives of general psychiatry.

[41]  S Giaquinto,et al.  The EEG in the normal elderly: a contribution to the interpretation of aging and dementia. , 1986, Electroencephalography and clinical neurophysiology.

[42]  John S. Barlow,et al.  Electroencephalography: Basic Principles, Clinical Applications and Related Fields , 1983 .

[43]  J. R. Hughes.  Electroencephalography. Basic principles, clinical applications and related fields , 1982 .

[44]  J C Shaw,et al.  The EEG and Differential Diagnosis in Psychogeriatrics , 1979, British Journal of Psychiatry.

[45]  J. Roubíček.  The Electroencephalogram in the Middle‐Aged and the Elderly , 1977, Journal of the American Geriatrics Society.

[46]  H. Nelson.  A Modified Card Sorting Test Sensitive to Frontal Lobe Defects , 1976, Cortex.

[47]  Alan D. Baddeley,et al.  The Rivermead Behavioural Memory Test - Extended Version , 1999 .

[48]  M. Mandelkern,et al.  EEG power correlates with subcortical metabolic activity in AIDS. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[49]  Hv Curran,et al.  Future perspectives for psychological research with MDMA ('ecstasy'). , 1997 .

[50]  Peter La Cour,et al.  Rivermead Behavioural Memory Test , 1990 .

[51]  E. Otomo,et al.  Electroencephalography in subjects sixty years and over. , 1966, Electroencephalography and clinical neurophysiology.